Cite
Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients.
MLA
Ramezani, Samaneh, et al. “Association of the Matrix Metalloproteinases (MMPs) Family Gene Polymorphisms and the Risk of Coronavirus Disease 2019 (COVID-19); Implications of Contribution for Development of Neurological Symptoms in the COVID-19 Patients.” Molecular Biology Reports, vol. 50, no. 1, Jan. 2023, pp. 173–83. EBSCOhost, https://doi.org/10.1007/s11033-022-07907-y.
APA
Ramezani, S., Ezzatifar, F., Hojjatipour, T., Hemmatzadeh, M., Shabgah, A. G., Navashenaq, J. G., Aslani, S., Shomali, N., Arabi, M., Babaie, F., Jadidi-Niaragh, F., Hosseinzadeh, R., Feizisani, F., Khodayar, S., Safari, R., & Mohammadi, H. (2023). Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients. Molecular Biology Reports, 50(1), 173–183. https://doi.org/10.1007/s11033-022-07907-y
Chicago
Ramezani, Samaneh, Fatemeh Ezzatifar, Tahereh Hojjatipour, Maryam Hemmatzadeh, Arezoo Gowhari Shabgah, Jamshid Gholizadeh Navashenaq, Saeed Aslani, et al. 2023. “Association of the Matrix Metalloproteinases (MMPs) Family Gene Polymorphisms and the Risk of Coronavirus Disease 2019 (COVID-19); Implications of Contribution for Development of Neurological Symptoms in the COVID-19 Patients.” Molecular Biology Reports 50 (1): 173–83. doi:10.1007/s11033-022-07907-y.